NCT00208260: Intensified Chemotherapy in CRC After Resection of Liver Metastases |
|
|
| Completed | 3 | 124 | Europe | FOLFIRI, FOLFOX-4, FOLFIRI-HD, FOLFOX-7, FOLFIRINOX | Institut du Cancer de Montpellier - Val d'Aurelle, Pfizer, Sanofi, Chugai Pharmaceutical | Colorectal Cancer, Liver Metastases, Chemotherapy | | 08/07 | | |
NCT00143403: Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer |
|
|
| Completed | 3 | 321 | Europe, RoW | Irinotecan + 5 FU + folinic acid, Folinic Acid + 5 FU | Pfizer | Colorectal Neoplasms, Liver Neoplasms | 02/08 | 09/09 | | |
NCT00440310 / 2006-004214-41: Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases |
|
|
| Completed | 3 | 483 | Europe, RoW | Talaporfin sodium, Percutaneous placement of device in liver metastases, Interstitial light emitting diodes, FOLFOX4 regimen, FOLFIRI regimen | Light Sciences Oncology | Liver Metastases, Colorectal Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local | 05/11 | 10/11 | | |
